Last reviewed · How we verify

NCT05047835

Comparison of Prone Position and Standard Electrocardiogram in COVID-19 Patients

Status unknown Last updated 10 October 2023
What this trial tests

trial testing electrocardiogram in COVID-19 Acute Respiratory Distress Syndrome in 60 participants. Status unknown.

Timeline
10 September 2021
Primary endpoint
30 April 2023
31 December 2023

Quick facts

Lead sponsorKhon Kaen University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment60
Start date10 September 2021
Primary completion30 April 2023
Estimated completion31 December 2023
Sites1 location across Thailand

Drugs / interventions tested

Conditions studied

Sponsor

Khon Kaen University

Who can join

Adults 18 to 80, any sex, with COVID-19 Acute Respiratory Distress Syndrome or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prolonged prone position ventilation reduces the 30-day mortality in acute respiratory distress syndrome (ARDS) and in COVID-19 infection. A large number of patients with COVID-19 suffered from new-onset cardiac disease, therefore, ECG is crucial. However, there is limited data on the effects of prone position on the ECG in COVID-19 patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of electrocardiogram

Trials testing the same drug.

Other recruiting trials for COVID-19 Acute Respiratory Distress Syndrome

Currently open trials in the same condition.

Other Khon Kaen University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05047835.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing